CanSino Biologics, Inc. Class H's total assets for Q3 2025 were ¥7.98B, an increase of 3.57% from the previous quarter. HK:6185 total liabilities were ¥2.59B for the fiscal quarter, a -7.55% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.